The shift to Eastern Europe appeared to be motivated by the search for cheaper venues for patient trials, as well the identification of patient pools which have not been exposed to treatment by existing medicines that could skew results of clinical tests using new drugs, Reuters added. Hungary’s University of Pécs cardiology head Dr. Iván Horváth said motivation for going to Eastern Europe for the tests was high for several practical reasons – It provides patients with new drugs for free, it is a generous source of revenue for hospitals used in the tests, and it advances medical science in a big way.
Producing journalism that is worthy of the name is a costly business. For over 30 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
